Premature Atherosclerosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-06
Clinical Trial Update: The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD [Phase 2]
This is a Phase 2 clinical trial assessing whether anifrolumab improves vascular risk markers in systemic lupus erythematosus; the study is …